FolioLanternBeta
ABTAbbott Laboratories

Kevin Conroy

Director at Abbott Laboratories, as of Oct 2, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
81K
shares held after the latest filing, Abbott Laboratories
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
3
companies filed for

Last filing: Oct 2, 2026.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Abbott Laboratories (ABT)DirectorApr 28, 2026Oct 2, 2026
Align Technology (ALGN)DirectorDec 7, 2023May 22, 2026
Adaptive Biotechnologies Corp (ADPT)Former DirectorJun 26, 2019Mar 8, 2023

Also a director at

Align Technology (ALGN), Adaptive Biotechnologies Corp (ADPT) (no filing in the last 18 months)

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.